Last kr34.40 SEK
Change Today -0.10 / -0.29%
Volume 30.8K
As of 11:30 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

cellavision ab (CEVI) Snapshot

Open
kr34.50
Previous Close
kr34.50
Day High
kr34.80
Day Low
kr34.10
52 Week High
11/18/14 - kr35.00
52 Week Low
11/22/13 - kr14.10
Market Cap
820.5M
Average Volume 10 Days
106.2K
EPS TTM
kr0.79
Shares Outstanding
23.9M
EX-Date
05/8/14
P/E TM
43.5x
Dividend
kr0.50
Dividend Yield
1.45%
Current Stock Chart for CELLAVISION AB (CEVI)

Related News

No related news articles were found.

cellavision ab (CEVI) Related Businessweek News

No Related Businessweek News Found

cellavision ab (CEVI) Details

CellaVision AB (publ) develops and sells systems for routine analysis of blood and other body fluids in health care services sector. It offers analyzers, supplementary software, and peripheral equipment in the hematology area of analysis. Its products include CellaVision DM96 and CellaVision DM1200, which automatically performs a preliminary differential count on peripheral blood or body fluid smears, as well as pre-classifies the white blood cells, pre-characterizes parts of the red morphology, and provides functionality for platelet estimation; DI-60, an automated analysis line for hematology; and CellaVision DM96 Vet blood analyzer for commercial veterinary laboratories. The company’s software and tool products comprise CellaVision Body Fluid Application for analyzing body fluids, including cerebrospinal, pleural and synovial fluids; CellaVision Remote Review Software that enables remote users to access analyzed slides and reclassify cells and sign slides from another location; CellaVision Proficiency Software, a Web-based program for testing of blood and body fluid differentials; CellaVision Image Capture System, for digitization of white blood cells using an existing microscope.; CellaVision Peripheral Blood Application for white blood cell differential, red blood cell characterization, and platelet estimation; and CellAtlas, a mobile application, as well as CellaVision Remote Review Software Vet software and tool. It also offers CellaVision Light Tower that provides visual and audible signals of the status of a CellaVision DM Analyzer; HemaPrep, an automated blood smearing instrument for blood cell analysis; and barcode label printer kit for reading and copying barcodes and generating barcode labels. The company sells its products to hospital laboratories and commercial laboratories in Europe, the Middle East, Africa, North America, and the Asia Pacific. CellaVision AB (publ) was founded in 1994 and is headquartered in Lund, Sweden.

72 Employees
Last Reported Date: 11/5/14
Founded in 1994

cellavision ab (CEVI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cellavision ab (CEVI) Key Developments

CellaVision AB Announces Executive Changes

CellaVision AB announced that Zlatko Rihter has been appointed as President/CEO, starting on February 1, 2015, and Yvonne Martensson will leave the position as President/CEO of the company on the last day of December.

CellaVision AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

CellaVision AB reported earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net sales of SEK 47 million compared to SEK 45.1 million a year ago. Operating profit was SEK 7.7 million compared to SEK 10.7 million a year ago. Profit before tax was SEK 7.9 million compared to SEK 10.4 million a year ago. Cash flow was SEK 12.3 million compared to SEK 1.5 million a year ago. Earnings per share were SEK 0.20 compared to SEK 0.33 a year ago. For the quarter, the company reported net sales of SEK 144.4 million compared to SEK 115 million a year ago. Operating profit was SEK 26 million compared to SEK 9.6 million a year ago. Profit before tax was SEK 26.8 million compared to SEK 8.4 million a year ago. Cash flow was SEK 0.6 million compared to cash outflow of SEK 3.6 million a year ago. Earnings per share were SEK 0.83 compared to SEK 0.26 a year ago.

Cellavision AB Reports Group and Parent Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

CellaVision AB reported group and parent earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the group has posted net sales of SEK 54,154,000 against SEK 36,095,000 a year ago. Operating profit was SEK 10,801,000 against operating loss of SEK 375,000 a year ago. Profit before tax was SEK 11,435,000 against loss before tax of SEK 483,000 a year ago. Profit for the period was SEK 9,094,000 or SEK 0.38 before and after diluted per share against loss for the period of SEK 314,000 or SEK 0.01 before and after diluted per share a year ago. Cash flow from operations was SEK 2,502,000 against SEK 4,215,000 a year ago. For the six months, the group has posted net sales of SEK 97,391,000 against SEK 69,890,000 a year ago. Operating profit was SEK 18,309,000 against operating loss of SEK 1,042,000 a year ago. Profit before tax was SEK 18,866,000 against loss before tax of SEK 1,981,000 a year ago. Profit for the period was SEK 14,988,000 or SEK 0.63 before and after diluted per share against loss for the period of SEK 1,812,000 or SEK 0.08 before and after diluted per share a year ago. Cash flow from operations was SEK 31,905,000 against SEK 11,719,000 a year ago. For the quarter, the parent company has posted net sales of SEK 51,803,000 against SEK 32,824,000 a year ago. Operating profit was SEK 9,740,000 against operating loss of SEK 285,000 a year ago. Profit before tax was SEK 10,402,000 against loss before tax of SEK 336,000 a year ago. Profit for the period was SEK 8,113,000 against loss for the period of SEK 336,000 a year ago. For the six months, the parent company has posted net sales of SEK 93,328,000 against SEK 62,798,000 a year ago. Operating profit was SEK 16,610,000 against operating loss of SEK 699,000 a year ago. Profit before tax was SEK 17,244,000 against loss before tax of SEK 1,538,000 a year ago. Profit for the period was SEK 13,450,000 against loss for the period of SEK 1,538,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEVI:SS kr34.40 SEK -0.10

CEVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.81 USD +0.03
Siemens AG €93.73 EUR +2.70
Sysmex Corp ¥4,890 JPY +5.00
View Industry Companies
 

Industry Analysis

CEVI

Industry Average

Valuation CEVI Industry Range
Price/Earnings 24.6x
Price/Sales 3.8x
Price/Book 5.7x
Price/Cash Flow 24.6x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLAVISION AB, please visit www.cellavision.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.